Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme. (Q33403635)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme. |
scientific article |
Statements
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme (English)
Sue Wilson
Taina Taskila
Deborah D Stocken
Ashley Martin
Val Redman
28 January 2009
28 January 2009
1 reference
1 reference
1 reference